.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,840,275

« Back to Dashboard

Details for Patent: 5,840,275

Title: Ultrasonic contrast agent with polymeric gas or air filled microballoons
Abstract:Ultrasonic contrast compositions containing gas or air filled microballoons having a mean size in the range of 0.5 to 1000 microns bounded by a 50 to 500 nm thick biodegradable, interfacially deposited, synthetic polymer membrane which is deformable and resilient in an aqueous carrier liquid are described.
Inventor(s): Bichon; Daniel (Montpellier, FR), Bussat; Philippe (Collonges S/Saleve, FR), Schneider; Michel (Troinex, CH)
Assignee: Bracco International B.V. (NL)
Filing Date:Aug 16, 1994
Application Number:08/291,542
Claims:1. An ultrasonic contrast agent comprising a suspension of air or gas microballoons in a physiologically acceptable aqueous carrier liquid in a concentration of 10.sup.5 to 10.sup.10 microballoons/ml, the microballoons having a mean size in the range of 0.5 to 1,000 microns, are bounded by a soft, elastic, 50-500 nm thick polymer membrane filled with air or a physiologically acceptable gas, the membrane being temporarily deformable under pressure variations and made from a biodegradable, synthetic, resilient, interfacially depositable polymer selected from the group consisting of polysaccharides, polylactides, polyglycolides, copolymers of polylactides and polyglycolides, copolymers of lactides and lactones, poly-(ortho)esters, polydioxanone, poly-.beta.-aminoketones, polyphosphazenes, polyanhydrides and polyalkyl-(cyano)acrylates.

2. The ultrasonic contrast agent of claim 1, wherein the microballoons have size in the range of 0.5-10 .mu.m and the membrane is either impervious or permeable to bioactive liquids.

3. The ultrasonic contrast agent of claim 1, wherein the polymer membrane is porous and has porosity ranging from 50 to 2000 nanometers.

4. The ultrasonic contrast agent of claim 1, wherein the membrane polymer is polyglutanic or polyaspartic acid esters or amides and their copolymers with amino acids.

5. The ultrasonic contrast agent of claim 4, wherein the polyglutamic and aspartic acid esters or amides have side functions having formulae

or

or

wherein R is an alkyl or aryl substituent; R.sup.1 and R.sup.2 are H or lower alkyls, or R and R.sup.1 are connected together by a substituted or unsubstituted linking member to form a 5- or 6-membered ring; n is 1 or 2; p is 1, 2 or 3; m is an integer from 1 to 5 and X is a side chain of an amino acid residue.

6. The ultrasonic contrast agent of claim 1, wherein the polymer membrane also includes a plasticizer selected from isopropyl myristate and glyceryl monostearate.

7. The ultrasonic contrast agent of claim 1, wherein the polymer membrane also includes a surfactant.

8. The ultrasonic contrast agent of claim 1, wherein the polymer membrane also includes a phospholipid.

9. The ultrasonic contrast agent of claim 1, wherein the polymer membrane also includes a paraffin wax.

10. The ultrasonic contrast agent of claim 1, wherein microballoons are present in the suspension in a concentration of about 10.sub.6 to 10.sub.10 microballoons per ml.

11. The ultrasonic contrast agent of claim 10, wherein microballoons are present in the suspension in a concentration of about 10.sup.8 to 10.sup.10 microballoons per ml.

12. The ultrasonic contrast agent of claim 1, wherein the physiologically acceptable gas in the microballoons is selected from the group consisting of CO.sub.2, N.sub.2 O, methane, helium and a freon.

13. The ultrasonic contrast agent of claim 1, wherein the physiologically acceptable gas in the microballoons is a fluorine containing gas.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc